WuXi
Customers
1
1 disclosed
Suppliers
0
None disclosed
Largest customer
—
No % disclosed
Named-customer revenue
—
No estimate available
Latest period
Sep 30, 2026
10-Q filed 2026-11-04
How this is estimated
Dollars are the disclosed share × the discloser's revenue for that period, using the latest full year where available, or federal dollars obligated. Each side has its own scale.Customers 1
Companies that buy from WuXi, as either company disclosed it. Percentages are a share of WuXi revenue. 1 active, 0 lapsed.
| Company | % of WuXi revenue | Est. revenue | Period | Trend | Status | Source |
|---|---|---|---|---|---|---|
| VRDN Viridian Therapeutics, Inc.\DE |
Named | — | 3M 2026-09-30 | — | Active | 10-Q 2026-11-04 |
We currently rely on outside vendors, including WuXi, to manufacture our commercial supplies of veligrotug and our clinical supplies of our product candidates, and we plan to continue relying on third parties to manufacture veligrotug and our product candidates, devices, or device components, if approved, on a commercial scale. | ||||||
Alerts are coming
Get an email when WuXi's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.